Arcellx (ACLX) Cash & Equivalents (2021 - 2025)

Arcellx (ACLX) recorded quarterly Cash & Equivalents of $80.3 million in Q4 2025, up 1.59% quarter-over-quarter from $79.0 million in Q3 2025, and down 24.05% on a YoY basis from $105.7 million in Q4 2024.

Arcellx (ACLX) Cash & Equivalents (2021 - 2025) Analysis & Trends

Arcellx's Cash & Equivalents history runs 5 years deep, the most recent figure standing at $80.3 million for Q4 2025.

  • In Q4 2025, Cash & Equivalents fell 24.05% year-over-year to $80.3 million; the TTM figure through Dec 2025 stood at $80.3 million (down 24.05% YoY), while the FY2025 annual figure was $80.3 million, down 24.05% from the prior year.
  • Cash & Equivalents was $80.3 million for Q4 2025 at Arcellx, up from $79.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $394.6 million in Q4 2023 to a low of $30.8 million in Q4 2021.
  • Historically, Cash & Equivalents has averaged $134.9 million across 5 years, with a median of $111.7 million in 2021.
  • The sharpest annual moves came in 2023 and 2024: Cash & Equivalents jumped 514.82% in 2023, then plunged 73.22% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $30.8 million in 2021, then jumped by 108.15% to $64.2 million in 2022, then surged by 514.82% to $394.6 million in 2023, then slumped by 73.22% to $105.7 million in 2024, then retreated by 24.05% to $80.3 million in 2025.
  • The last three Cash & Equivalents figures came in at $80.3 million (Q4 2025), $79.0 million (Q3 2025), and $62.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 1.91 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.49 Bn
9 Abivax 91.96 Bn 91.96 Bn - 558.94 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 80.26 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 80.26 Mn
Sep 30, 2025 79.01 Mn
Jun 30, 2025 62.34 Mn
Mar 31, 2025 80.86 Mn
Dec 31, 2024 105.68 Mn
Sep 30, 2024 161.85 Mn
Jun 30, 2024 100.03 Mn
Mar 31, 2024 154.57 Mn
Dec 31, 2023 394.58 Mn
Sep 30, 2023 126.12 Mn
Jun 30, 2023 303.67 Mn
Mar 31, 2023 274.89 Mn
Dec 31, 2022 64.18 Mn
Sep 30, 2022 56.76 Mn
Jun 30, 2022 164.54 Mn
Mar 31, 2022 127.16 Mn
Dec 31, 2021 30.83 Mn
Sep 30, 2021 70.03 Mn
Jun 30, 2021 143.79 Mn
Mar 31, 2021 117.65 Mn